Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary

Q: What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?

Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 95.706K
Day Range	- - -
52 Wk Range	1.170 - 8.820
Market Cap	$35.138M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	2.53%
Days to Cover	2.5

Recent News

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter.

Priya Nigam

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Avi Kapoor

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Acurx Pharmaceuticals' ibezapolstat outperforms vancomycin with a 94% eradication rate. Stay tuned for Q1 2024 updates on Extended Clinical Cure and microbiome data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acurx Pharmaceuticals (ACXP) stock?

You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.

View our list of the best stock brokerages.

Who are Acurx Pharmaceuticals's (ACXP) competitors?

Other companies in Acurx Pharmaceuticals’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and T2 Biosystems (NASDAQ:TTOO).

What is the target price for Acurx Pharmaceuticals (ACXP) stock?

The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 12.00 expecting ACXP to rise to within 12 months (a possible 438.12% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Acurx Pharmaceuticals (ACXP)?

The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $2.23 last updated April 30, 2024 at 6:58 PM EDT.

Does Acurx Pharmaceuticals (ACXP) pay a dividend?

There are no upcoming dividends for Acurx Pharmaceuticals.

When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?

Acurx Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 15, 2024.

Is Acurx Pharmaceuticals (ACXP) going to split?

There is no upcoming split for Acurx Pharmaceuticals.

What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?

Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-